Bradley B. Miller
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research, Neuroinflammation and Neurodegeneration Mechanisms, Mitochondrial Function and Pathology, Advanced Neuroimaging Techniques and Applications
Most-Cited Works
- → Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids(2011)571 cited
- → Regional profiles of the candidate tau PET ligand 18 F-AV-1451 recapitulate key features of Braak histopathological stages(2016)429 cited
- → Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases(2011)200 cited
- → Digital technologies as biomarkers, clinical outcomes assessment, and recruitment tools in Alzheimer's disease clinical trials(2018)150 cited
- → MRI characteristics and scoring in HDLS due to CSF1R gene mutations(2012)111 cited
- → Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal model(2018)89 cited
- → Parkinsonian features in hereditary diffuse leukoencephalopathy with spheroids (HDLS) and CSF1R mutations(2013)70 cited
- → Topographic staging of tau positron emission tomography images(2018)67 cited
- → Analysis of the caudate nucleus transcriptome in individuals with schizophrenia highlights effects of antipsychotics and new risk genes(2022)65 cited
- → Mitochondrial genomic contribution to mitochondrial dysfunction in Alzheimer's disease(2006)59 cited